Association of the mu-opioid receptor gene with smoking cessation (original) (raw)
Doll R, Peto R, Boreham J, Sutherland I . Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004; 328: 1519. ArticlePubMedPubMed Central Google Scholar
Munafo M, Clark T, Johnstone E, Murphy M, Walton R . The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 2004; 6: 583–597. ArticleCASPubMed Google Scholar
Boyadjieva NI, Sarkar DK . The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci 1997; 61: PL59–PL66. ArticleCASPubMed Google Scholar
Robinson TE, Berridge KC . The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18: 247–291. ArticleCASPubMed Google Scholar
Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006; 31: 231–242. ArticleCASPubMed Google Scholar
Yudkin P, Munafo M, Hey K, Roberts S, Welch S, Johnstone E et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 2004; 328: 989–990. ArticlePubMedPubMed Central Google Scholar
Munafo MR, Johnstone EC, Wileyto EP, Shields PG, Elliot KM, Lerman C . Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 398–400. ArticleCASPubMed Google Scholar
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004; 4: 184–192. ArticleCASPubMed Google Scholar
Gianoulakis C . Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 2001; 26: 304–318. CASPubMedPubMed Central Google Scholar
Pastor R, Aragon CM . The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol. Neuropsychopharmacology 2005; 31: 1489–1499. ArticlePubMed Google Scholar
Davenport KE, Houdi AA, Van Loon GR . Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci Lett 1990; 113: 40–46. ArticleCASPubMed Google Scholar
Dilts RP, Kalivas PW . Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 1989; 488: 311–327. ArticleCASPubMed Google Scholar
Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ . Anatomy of CNS opioid receptors. Trends Neurosci 1988; 11: 308–314. ArticleCASPubMed Google Scholar
Xi ZX, Stein EA . GABAergic mechanisms of opiate reinforcement. Alcohol Alcohol 2002; 37: 485–494. ArticleCASPubMed Google Scholar
Lee FJ, Wang YT, Liu F . Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine. J Mol Neurosci 2005; 26: 245–252. ArticleCASPubMed Google Scholar
Kelley AE, Stinus L, Iversen SD . Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat. Behav Brain Res 1980; 1: 3–24. ArticleCASPubMed Google Scholar
Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W . Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 2005; 280: 32618–32624. ArticleCASPubMed Google Scholar
Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608–9613. ArticleCASPubMedPubMed Central Google Scholar
Beyer A, Koch T, Schroder H, Schulz S, Hollt V . Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 2004; 89: 553–560. ArticleCASPubMed Google Scholar
Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C, Hoehe MR, Kieffer BL . A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem 2001; 276: 3130–3137. ArticleCASPubMed Google Scholar
Ray LA, Hutchison KE . A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 2004; 28: 1789–1795. ArticleCASPubMed Google Scholar
Zhang L, Kendler KS, Chen X . The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct 2006; 2: 28. ArticlePubMedPubMed Central Google Scholar
Sullivan PF, Neale BM, van den Oord E, Miles MF, Neale MC, Bulik CM et al. Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet 2004; 126: 23–36. Article Google Scholar
Becker A, Grecksch G, Kraus J, Loh HH, Schroeder H, Hollt V . Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 296–302. ArticleCASPubMed Google Scholar
Berrendero F, Kieffer BL, Maldonado R . Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002; 22: 10935–10940. ArticleCASPubMedPubMed Central Google Scholar
Contarino A, Picetti R, Matthes HW, Koob GF, Kieffer BL, Gold LH . Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. Eur J Pharmacol 2002; 446: 103–109. ArticleCASPubMed Google Scholar
Hall FS, Sora I, Uhl GR . Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 2001; 154: 43–49. ArticleCAS Google Scholar
Hall FS, Goeb M, Li XF, Sora I, Uhl GR . Micro-opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. Brain Res Mol Brain Res 2004; 121: 123–130. ArticleCASPubMed Google Scholar
Bohadana A, Nilsson F, Rasmussen T, Martinet Y . Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res 2003; 5: 111–116. ArticlePubMed Google Scholar
Munafo M, Bradburn M, Bowes L, David S . Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res 2004; 6: 769–776. ArticleCASPubMed Google Scholar
Perkins KA, Donny E, Caggiula AR . Sex differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine Tob Res 1999; 1: 301–315. ArticleCASPubMed Google Scholar
Cicero TJ, Aylward SC, Meyer ER . Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav 2003; 74: 541–549. ArticleCASPubMed Google Scholar
Craft RM, Kalivas PW, Stratmann JA . Sex differences in discriminative stimulus effects of morphine in the rat. Behav Pharmacol 1996; 7: 764–778. CASPubMed Google Scholar
Lynch WJ, Carroll ME . Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology (Berl) 1999; 144: 77–82. ArticleCAS Google Scholar
Zubieta JK, Dannals RF, Frost JJ . Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 1999; 156: 842–848. ArticleCASPubMed Google Scholar
Micevych PE, Rissman EF, Gustafsson JA, Sinchak K . Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization. J Neurosci Res 2003; 71: 802–810. ArticleCASPubMed Google Scholar
Mills RH, Sohn RK, Micevych PE . Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats. J Neurosci 2004; 24: 947–955. ArticleCASPubMedPubMed Central Google Scholar
Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K et al. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl) 2006; 188: 355–363. ArticleCAS Google Scholar
Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA et al. The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav 2006; 31: 1144–1152. ArticlePubMed Google Scholar
Samet JM . The 1990 report of the surgeon general: the health benefits of smoking cessation. Am Rev Respir Dis 1990; 142: 993–994. ArticleCASPubMed Google Scholar
Hall SM, Havassy BE . Commitment to abstinence and relapse to tobacco, alcohol, and opiates. NIDA Res Monogr 1986; 72: 118–135. CASPubMed Google Scholar
Grunberg NE . Nicotine as a psychoactive drug: appetite regulation. Psychopharmacol Bull 1986; 22: 875–881. CASPubMed Google Scholar
Grunberg NE, Bowen DJ, Winders SE . Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berl) 1986; 90: 101–105. ArticleCAS Google Scholar
Miyata G, Meguid MM, Fetissov SO, Torelli GF, Kim HJ . Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery 1999; 126: 255–263. ArticleCASPubMed Google Scholar
Hatsukami DK, Hughes JR, Pickens RW, Svikis D . Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology (Berl) 1984; 84: 231–236. ArticleCAS Google Scholar
Perkins KA, Epstein LH, Sexton JE, Pastor S . Effects of smoking cessation on consumption of alcohol and sweet, high-fat foods. J Subst Abuse 1990; 2: 287–297. ArticleCASPubMed Google Scholar
Spring B, Wurtman J, Gleason R, Wurtman R, Kessler K . Weight gain and withdrawal symptoms after smoking cessation: a preventive intervention using _d_-fenfluramine. Health Psychol 1991; 10: 216–223. ArticleCASPubMed Google Scholar
Swan GE, Carmelli D . Characteristics associated with excessive weight gain after smoking cessation in men. Am J Public Health 1995; 85: 73–77. ArticleCASPubMedPubMed Central Google Scholar
Munafo MR, Murphy MF, Johnstone EC . Smoking cessation, weight gain, and DRD4 -521 genotype. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 398–402. Article Google Scholar
John U, Meyer C, Rumpf HJ, Hapke U, Schumann A . Predictors of increased body mass index following cessation of smoking. Am J Addict 2006; 15: 192–197. ArticlePubMed Google Scholar
Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T . Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991; 324: 739–745. ArticleCASPubMed Google Scholar
Fox CS, Heard-Costa NL, Wilson PW, Levy D, D'Agostino Sr RB, Atwood LD . Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study. Diabetes 2004; 53: 1399–1402. ArticleCASPubMed Google Scholar
Appleyard SM, Hayward M, Young JI, Butler AA, Cone RD, Rubinstein M et al. A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology 2003; 144: 1753–1760. ArticleCASPubMed Google Scholar
Low MJ, Hayward MD, Appleyard SM, Rubinstein M . State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin. Ann NY Acad Sci 2003; 994: 192–201. ArticleCASPubMed Google Scholar
Filozof C, Fernandez Pinilla MC, Fernandez-Cruz A . Smoking cessation and weight gain. Obes Rev 2004; 5: 95–103. ArticleCASPubMed Google Scholar
Wewers ME, Dhatt RK, Snively TA, Tejwani GA . The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats. Brain Res 1999; 822: 107–113. ArticleCASPubMed Google Scholar
Mayer P, Hollt V . Pharmacogenetics of opioid receptors and addiction. Pharmacogenet Genomics 2006; 16: 1–7. ArticleCASPubMed Google Scholar
Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E et al. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 2006; 15: 807–819. ArticleCASPubMed Google Scholar
ICRF. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993; 306: 1304–1308.
Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004; 14: 83–90. ArticleCASPubMed Google Scholar
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215. ArticleCASPubMedPubMed Central Google Scholar